Academic Journal
Q1Atherosclerosis
About Atherosclerosis
Atherosclerosis is a scholarly journal published by Elsevier Ireland Ltd. SCImago 2025 places it in Q1 with an SJR of 2.182 and an H-index of 207.
Its listed coverage is 1970-2026 and its research categories include Cardiology and Cardiovascular Medicine (Q1). The 2025 dataset reports 292 documents and 4117 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Atherosclerosis and Cardiovascular Diseases, Cancer, Lipids, and Metabolism, Adipokines, Inflammation, and Metabolic Diseases, Cardiovascular Disease and Adiposity.
Recent Research Articles
Latest publications matched automatically by ISSN.
Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies
Filippo Biondi, Sandra Ghelardoni, Emilia Monti, Ashot Avagimyan et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121898Impact of saturated fat absorption on serum low density lipoprotein-cholesterol response to the replacement of saturated with unsaturated fats in healthy males. The ‘Reading, Imperial, Surrey, Saturated fat Cholesterol Intervention-2 (RISSCI-2)’ non-randomised sequential dietary intervention study
Barbara A. Fielding, Athanasios Koutsos, Rona Antoni, Ezgi Ozen et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121884The hidden atherogenic burden of lipoprotein(a): Reclassification by risk-weighted apoB in a multicenter registry
Pablo Corral, Maria Gabriela Matta, Sebastian Garcia-Zamora, Natalia Nardelli et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121880Transcriptomic profiling identifies tumor necrosis factor receptor-associated factor (TRAF)-5 expression in human atherosclerotic plaques as a predictor of future cardiovascular events
Mark Colin Gissler, Xin Gu, Floor B.H. van der Zalm, Hauke Horstmann et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121886Development of a dynamic risk prediction tool for identifying individuals at high risk of cardiovascular diseases: A post-hoc analysis of the multi-ethnic study of atherosclerosis
Abderrahim Oulhaj, Abubaker Suliman, Dian Kusuma, Rury R. Hollman et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121877Circulating biomarkers and polygenic scores for cardiovascular risk prediction in healthy older adults: differential and complementary contributions
Chenglong Yu, Cammie Tran, Johannes T. Neumann, Le T.P. Thao et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121881Ultrasound-detected fatty liver in young adults and long-term risk of atherosclerotic cardiovascular disease: The Young Finns Study
Olli Raitakari, Katja Pahkala, Suvi Rovio, Juha Mykkänen et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121882Roles of primary cilia in cardiovascular diseases: mechanisms and therapeutic prospects
Zhuangzhuang Yang, Yongsong Tang, Boyu Guan, Chenchen Zhao et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121878Discordant fatty acid profile drives residual inflammatory risk in metabolically vulnerable patients with low atherogenic lipoprotein burden
Yuan Wang, Chaohui Han, Jiahui Yao, Yanjing Feng et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121885Lipid profile in pediatric and adult patients with lysosomal acid lipase deficiency treated with sebelipase alfa: longitudinal evidence from the International LAL-D Registry
Don P. Wilson, Lorenzo D'Antiga, Manisha Balwani, Annalisa Madeo et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121867Real-world variability and factors associated with individual low-density-lipoprotein cholesterol response to different doses of atorvastatin, rosuvastatin, and simvastatin in 28,647 Chinese patients
Yuexi Liao, Wai Ki Keith Cheung, Ralph K. Akyea, Brian Tomlinson et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121876The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion
Grigorios Panteloglou, Jérôme Robert, Marieke Smit, Nicolette Huijkman et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121887Long-term average atherogenic index of plasma and cardiovascular mortality in 8.9 million Korean adults: A nationwide cohort study
Hyeon Hui Kang, Yoonjong Bae, Hoseob Kim, Ki-Bum Won et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121879The benefit of LDL-C levels below 55 mg/dL in ESKD patients under statin treatment: A target trial emulation study
Chieh-Li Yen, Pei-Chun Fan, Jia-Jin Chen, Cheng-Chia Lee et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121883IL-21R blockade reduces inflammation and atherosclerosis in LDL receptor deficient mice
Roy P.M. Snijckers, Virginia Smit, Rimke J. Postel, Marie A.C. Depuydt et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121899Effect of in-hospital initiation of alirocumab on clinical outcomes in Chinese ACS patients: findings from the Chinese Cardiovascular Association (CCA) Database-Chest Pain Center
Yani Yu, Dandan Li, Dongkai Shan, Ying Wang et al.
2026-10 · DOI: 10.1016/j.atherosclerosis.2026.121864The adventitia, vascular inflammation, and the intersection of hypertension and vascular disease
David G. Harrison
2026-09 · DOI: 10.1016/j.atherosclerosis.2026.121860Hematopoietic loss of Y chromosome and risk of symptomatic peripheral artery disease in men
Chenshu Li, Dongdong Tang, Sultana Monira Hussain, Kailang Liu et al.
2026-09 · DOI: 10.1016/j.atherosclerosis.2026.121859Editorial Board
2026-09 · DOI: 10.1016/j.atherosclerosis.2026.121891Associations Between Vascular Aging and 12 Lipid Composite Indices: A Large Cross-Sectional Study
Zhuoji Ma, Lijiao Xiong, Yunfei Huang, Yunting Mei et al.
2026-09 · DOI: 10.1016/j.atherosclerosis.2026.121897Reviews
Community Reviews
Version History
September 8, 2026 at 12:02 am
September 8, 2026